-
Nearly 47 million Americans lack health insurance, leaving them without regular access to health care and making them a potentially vulnerable population in health care research.
-
IRB offices no longer can use the trial-by-fire method of new board member training.
-
The number, type, and severity of comorbidities are important determinants of diabetes self-care.
-
Patients with mild-to-moderate obstructive sleep apnea (OSA) who were treated with Continuous Positive Airway Pressure (CPAP) experienced an absolute risk reduction in cardiovascular risk compared with those who were not treated.
-
Absent or low testosterone levels in men appear to have a pathogenic role in the development of cardiovascular disease resulting in increased cardiovascular and all-cause mortality and are not simply "markers" for illness or wellness.
-
The FDA has approved, by priority review, the first drug to help manage patients with phenylketonuria (PKU).
-
Fenofibrate for Diabetic Retinopathy, Does Obesity Cause A Delay in Diagnosis of Prostate Cancer?, and Protecting Bone During Glucocorticoid Treatment
-
-
Research conducted at the Detroit Medical Center found that Cubist Pharmaceuticals' daptomycin for injection (Cubicin®) outperformed vancomycin in resolving the signs and symptoms of complicated skin and skin structure infections.
-
When pharmacists run diabetes management programs for HMO patients, the patients have better health outcomes than patients who are only monitored for long-term blood sugar control. That's the takeaway from a nine-month study that evaluated the effect of such pharmacist-run diabetes management programs.
